Search Within

Mario E Lacouture

Formats
  1. Journal Article (220)
  2. Meeting Abstract (171)
  3. Book Section (25)
  4. Review (18)
  5. Research Letter (9)
  6. Guidelines (5)
  7. Book Whole (2)
  8. Conference Paper (2)
  9. Editorial (2)
  10. Miscellaneous (2)
  11. Correspondence (1)
Groups
  1. Department of Medicine (457)
  2. Dermatology (457)
  3. Dermatology Service (457)
  4. Division of Subspecialty Medicine (457)
  5. Survivorship Research (457)
  6. Solid Tumor Oncology Division (142)

More Groups

People
  1. Viswanath Reddy Belum (37)
  2. Shari Goldfarb (34)
  3. Alina Markova (31)
  4. Azael Freites Martinez (27)
  5. Yevgeniy Balagula (26)
  6. Stephen Dusza (25)

More People

Years
  1. 2025 (4)
  2. 2024 (17)
  3. 2023 (24)
  4. 2022 (31)
  5. 2021 (32)
  6. 2020 (27)

More Years

Publications
  1. Journal of Clinical Oncology (90)
  2. Journal of the American Academy of Dermatology (51)
  3. Annals of Oncology (20)
  4. Supportive Care in Cancer (17)
  5. The Oncologist (16)
  6. Blood (12)

More Publications

Publishers
  1. American Society of Clinical Oncology (92)
  2. Mosby Elsevier (55)
  3. Oxford University Press (44)
  4. Elsevier Inc. (35)
  5. Springer (34)
  6. Wiley Blackwell (29)

More Publishers

Results (457)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinical characteristics and treatment outcomes in patients with histiocytic neoplasms harboring class 3 MAP2K1 mutations, including novel treatment with the ERK inhibitor ulixertinib
    Meeting Abstract

    Diamond, E. L.; Rosenblum, M.; Yabe, M.; Petrova-Drus, K.; Francis, J. H.; Rampal, R. K.; Lacouture, M. E.; Rotemberg, V. M.; Hatzoglou, V.; Young, R.; more...
    Pediatric Blood and Cancer (2023)

    Fulltext@MSK | Save
  • A multinational series of 26 patients with mixed histiocytic neoplasms highlighting a diverse mutational landscape and superior efficacy of targeted therapies
    Meeting Abstract

    Diamond, E. L.; Durham, B. H.; Reiner, A. S.; Yabe, M.; Petrova-Drus, K.; Francis, J. H.; Rampal, R. K.; Ulaner, G. A.; Reddy, R.; Lacouture, M. E.; more...
    Pediatric Blood and Cancer (2023)

    Fulltext@MSK | Save
  • NOVA-II: Part 2 study to evaluate the safety and efficacy of OQL011 on VEGF inhibitor-associated hand-foot skin reaction in patients with cancer
    Meeting Abstract

    Patel, A. B.; Anadkat, M. J.; Marathe, O. S.; Webb, M. L.; Tyler, R. C.; Zhang, W.; Wu, C.; Ju, J.; Tang, H.; Luo, J.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Dermatologic immune-related adverse events to checkpoint inhibitors in cancer
    Editorial

    Shah, N. J.; Lacouture, M. E.
    Journal of Allergy and Clinical Immunology (2023)

    Fulltext@MSK | Save
  • Dermatologist awareness of scalp cooling for chemotherapy-induced alopecia
    Research Letter

    Yin, L.; Klein, E. J.; Svigos, K.; Novice, T.; Gutierrez, D.; Oratz, R.; Lacouture, M. E.; Powers, M.; Senna, M.; Shapiro, J.; more...
    Journal of the American Academy of Dermatology (2023)

    Fulltext@MSK | Save
  • Noninvasive, in vivo, characterization of cutaneous metastases using a novel multimodal RCM-OCT imaging device: A case-series
    Meeting Abstract

    Monnier, J.; Bang, A. S.; Harris, U.; Garfinkel, J.; Rubinstein, G.; Iftimia, N.; Pulitzer, M.; Murray, M.; Lacouture, M. E.; Jain, M.
    Journal of the American Academy of Dermatology (2022)

    Fulltext@MSK | Save
  • Expert guidance on prophylaxis and treatment of dermatologic adverse events with Tumor Treating Fields (TTFields) therapy in the thoracic region
    Review

    Anadkat, M. J.; Lacouture, M.; Friedman, A.; Horne, Z. D.; Jung, J.; Kaffenberger, B.; Kalmadi, S.; Ovington, L.; Kotecha, R.; Abdullah, H. I.; more...
    Frontiers in Oncology (2022)

    Fulltext@MSK | Save
  • United States Cutaneous Oncodermatology Management (USCOM) II: A multidisciplinary-guided algorithm for the prevention and management of acute radiation dermatitis in cancer patients
    Review

    Leventhal, J.; Lacouture, M. E.; Andriessen, A. E.; McLellan, B. N.; Ho, A.
    Journal of Drugs in Dermatology (2022)

    Fulltext@MSK | Save
  • Targeting insulin feedback to enhance alpelisib (TIFA): A phase II randomized trial in metastatic, PIK3CA-mutant, hormone receptor-positive breast cancer
    Meeting Abstract

    Shen, S.; Salehi, E.; Farooki, A.; Flory, J.; Williams, D.; Carpio, A.; Chang, C.; Lacouture, M. E.; Andreopoulou, E.; Sardesai, S. D.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • A survey study of prevention and treatment patterns by academic and community oncologists for papulopustular, acneiform skin rash associated with epidermal growth factor receptor inhibitor (EGFRi) therapy
    Meeting Abstract

    Lacouture, M. E.; Anadkat, M. J.; Patel, A. B.; Marathe, O. S.; Webb, M. L.; Tyler, R. C.; Chen, L.; Wu, C.; Li, W.; Ju, J.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save